Thursday, September 29, 2016
 
 
Video: Page (1) of 1 - 02/25/11 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
ViroPharma Up 2% as Q4 Profit Triples, Tops Street

By DMO Affiliate
ViroPharma (VPHM) is up 2.43% to $16.43, on positive 2010 Q4 results. The biotech company's quarterly profit tripled on increased sales of Cinryze and Vancocin. The company reported net income of $37.5 million, or 43 cents per share, up from $12 million,
ViroPharma Up 2% as Q4 Profit Triples, Tops Street




Page: 1


null
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The U.S. Daily News - Contact Us - Advertise With Us - Privacy Guidelines